(Date:10/13/2008)...wire/ -- The National Coalition for,Quality Colore...cerns over,the National CT Colonography Study publ...edicine. The evidence must be closely evaluated, a... is not without significant,potential risks. The N...y,remains the "Gold Standard" for colorectal cance...
(Date:10/13/2008)...-USNewswire/ -- The 2008 NCPA Digest,sponsored by...10th Annual,Convention. The Digest has been publis...st comprehensive portrait of the financial state o... calendar year. Last year,s,Digest provided an ins...,drug program had played a leading role in reducin...
(Date:10/13/2008)... after weekly doses up to 3 times recommended amou...-- Existing guidelines for treating vitamin D defi...w and put patients at high risk for bone loss and ...ohns Hopkins Children,s Center looked at 262 child...ldren were vitamin D-deficient, and most of them r...
(Date:10/13/2008)...bs.com and numerous newspaper affiliates have anno.... AtlantaJobs.com is the newest online job board ...kers in the metro Atlanta area. , ...AtlantaJobs.com and numerous newspaper affiliates...s.com is the newest online job board dedicated to...
Breaking Medicine News(10 mins):Health News:National Coalition for Quality Colorectal Cancer Screening and Care Conveys Concerns over CT Colonography 2Health News:National Coalition for Quality Colorectal Cancer Screening and Care Conveys Concerns over CT Colonography 3Health News:Positive Picture of Independent Community Pharmacies Emerges With Release of 2008 NCPA Digest, Sponsored by Cardinal Health 2Health News:Positive Picture of Independent Community Pharmacies Emerges With Release of 2008 NCPA Digest, Sponsored by Cardinal Health 3Health News:Vitamin D Guidelines Too Low for Cystic Fibrosis Kids 2Health News:Atlanta Area Job Board Launches New Local Job Board to Connect Local Employers and Jobseekers 2(Date:10/10/2008)...ll/ -- Boston Scientific,Corporation (NYSE: BSX )...or,events and press announcements at the Cardiovas... Transcatheter Cardiovascular Therapeutics (TCT),s... 17 in Washington, D.C., Boston Scientific will b...ata on its TAXUS(R) Express2(TM) and second-genera...
(Date:10/9/2008)...mber 2008, BOTHELL, Wash., Oct. 9 /PRNewswire-Fir...ced today the completion of patient enrollment and...to evaluate the safety and,efficacy of its formula...r,the over-the-counter (OTC) market. The Company e...l trial in November 2008. Ibuprofen is an analgesi...
(Date:10/8/2008)...or Spinal Cord, Other Nerve,Injuries -, PHILADELP...hat enables,nerve cells to communicate with each o...g nervous system. Research into how that protein h... may provide a basis for eventual,treatments for p...m,including spinal cord injury., "This expands o...
(Date:10/8/2008)... as Vaccine Adjuvant, SAN DIEGO, Oct. 8 /PRNewswi...tion (TSX: NVN) today presented positive data from...ke Receptor 3 agonist, Poly IC-Poly,Arginine (Poly... France.,Study results demonstrated Poly-ICR to be... Receptor 3 (TLR3) pathway. Data showed that,Poly-...
Breaking Medicine Technology:Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008 2Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008 3Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008 4Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008 5Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008 6SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen 2SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen 3Protein Shown to Play a Key Role in Normal Development of Nervous System 2Protein Shown to Play a Key Role in Normal Development of Nervous System 3Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 2Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 3Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 4Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 5MIT probe may help untangle cells signaling pathways 3797 1ABC News NIGHTLINE Features HIFU with Sonablate 28R 29 500 as Non Invasive Treatment Option for Prostate Cancer 2536 1ABC News NIGHTLINE Features HIFU with Sonablate 28R 29 500 as Non Invasive Treatment Option for Prostate Cancer 2536 2ABC News NIGHTLINE Features HIFU with Sonablate 28R 29 500 as Non Invasive Treatment Option for Prostate Cancer 2536 3Ricochet Public Relations Opens Washington D C Office 22885 1Ricochet Public Relations Opens Washington D C Office 22885 2Ricochet Public Relations Opens Washington D C Office 22885 3Michigan Health 26 Hospital Association Elects 2008 Officers and Board Members Bestows Awards 22883 1Michigan Health 26 Hospital Association Elects 2008 Officers and Board Members Bestows Awards 22883 2Michigan Health 26 Hospital Association Elects 2008 Officers and Board Members Bestows Awards 22883 3...owing Childhood Condition, WASHINGTON, May 22, 200...nt several studies today regarding pediatric patie...ring oral and poster,sessions at the annual Digest...nvention Center. , The studies being presented fur...in the area of gastrointestinal health among,the p...
...RNewswire/ -- NanoBio,Corporation, a biopharmaceut...atment and prevention of serious infections, today...linical study of,NB-002, the company,s drug candid...topical treatment of onychomycosis. , The Phase 1 ...nvolved 20 subjects who received twice-daily treat...
Other Medicine Technology:New Studies Evaluating NexiumIn Pediatric GERD To Be Presented At,Annual Digestive Disease Week Meeting 2New Studies Evaluating NexiumIn Pediatric GERD To Be Presented At,Annual Digestive Disease Week Meeting 3New Studies Evaluating NexiumIn Pediatric GERD To Be Presented At,Annual Digestive Disease Week Meeting 4New Studies Evaluating NexiumIn Pediatric GERD To Be Presented At,Annual Digestive Disease Week Meeting 5NanoBio Corporation Announces Positive Phase 1 Clinical Results for,Topical Treatment for Onychomycosis 2NanoBio Corporation Announces Positive Phase 1 Clinical Results for,Topical Treatment for Onychomycosis 3...fety and comfort of the practitioner in mind. Our ... glass, the industry standard for radiation shield... optical clarity, visible light transmission, powe...otecting your eyes, it also helps you look your be...
Radiation Protection Goggles fit over glasses and can be used by the whole department! 1.0 mm leaded glass, 1.0 mm leaded glass side shields provide increased scatter radiation protection. Clear viny
QualCraft™ Radiation-Reducing Eyewear is 50% lighter than other protective eyewear. Manufactured for the ultimate combination of comfort, function, and protection.
Clip-On Glasses clip onto regular eyewear frames. Plano (nonprescription) only. Will not fit over high-plus or high-minus presciptions, or over glasses with thick frames. Black wire frames. Wt. 63 g.
Medicine Products: